Journal Information
Vol. 35. Issue 1.
Pages 27-32 (January 1999)
Share
Share
Download PDF
More article options
Vol. 35. Issue 1.
Pages 27-32 (January 1999)
Full text access
Neumonía adquirida en la comunidad remitida al medio hospitalario. Epidemiología y actitud diagnóstica y terapéutica
Community-acquired pneumonia referred for hospital management: epidemiology and diagnostic and therapeutic approaches
Visits
4068
J.A. Carretero Graciaa,*, T. Nebreda Mayoralb, A.I. Acereda Ridruejoc, Y. Larumbe Solac, M.A. Martínez Gutiérrezc, C. Tierno Sanquiricoc
a Servicios de Medicina Interna. Unidad de Neumología
b Servicios de Microbiología. Hospital General de Soria.
c Servicios de Unidad Docente de Medicina Familiar y Comunitaria de Soria
This item has received
Article information
Abstract
Bibliography
Download PDF
Statistics
Objetivos

Conocer la situación epidemiológica de la neumonía adquirida en la comunidad remitida al medio hospitalario y la actitud diagnóstica y terapéutica que adopta el médico frente a la misma.

Método

Estudio epidemiológico retrospectivo y clínico descriptivo basado en la historia clínica de los pacientes con criterios de neumonía adquirida en la comunidad (Fang et al. Medicine 1990; 69: 307-316) remitidos a los hospitales de Soria durante un año. Los pacientes se agruparon en función de la gravedad y presencia de factores de riesgo para una etiología no habitual y se comparó la actitud inicial con la propuesta por diversas normativas.

Resultados

Se diagnosticaron 308 neumonías adquiridas en la comunidad; ingresaron el 82%. La edad media de los pacientes fue de 68 ± 26 años (el 43% mayores de 80 años). El 56% fueron varones; 217 (70%) tenían criterios de gravedad, 203 (66%) tenían factores de riesgo para una etiología no habitual y 166 (54%) ambos. La mortalidad global en los ingresados fue del 13%. La investigación etiológica no se ajustó a la normativa de la Sociedad Española de Neumología y Cirugía Torácica (SEPAR), logrando una identificación microbiológica en un 5% de los pacientes. El tratamiento empírico se ajustó a normativa SEPAR en el 45% de los casos, en el 23% a la guía Mensa y en el 20% a la guía Sanford.

Conclusiones

La incidencia de neumonía adquirida en la comunidad en este estudio es de 3,2 casos por 1.000 habitantes/año, población mayoritariamente envejecida y con frecuente comorbilidad aunque la mortalidad global es baja. Creemos necesario adoptar criterios comunes en el manejo de la neumonía adquirida en la comunidad y ajustar el tratamiento empírico a los gérmenes identificados en cada medio realizando una investigación etiológica correcta.

Palabras clave:
Neumonía adquirida en la comunidad
Objectives

To determine the epidemiology of community acquired pneumonia referred to the hospital and to characterize the diagnostic and therapeutic approach adopted by physicians.

Method

Retrospective epidemiological and descriptive ciinical study based on case histories consistent with a diagnosis of community-acquired pneumonia (Fang et al. Medicine, 1990; 69:307-16) of patients referred to hospitals in Soria (Spain) over a period of one year. The patients were grouped by severity and the presence of risk factors for unusual etiology. Initial approaches were compared to those advocated by various sources.

Results

Three hundred eight cases of community-acquired pneumonia were diagnosed, and 82% of the patients were admitted. Mean age was 68±26 years (43% over 80 years of age). Men accounted for 56%. Two hundred seventeen patients (70%) were classified as seriously ill, 203 (66%) had risk factors for unusual etiology, and 166 (54%) were classified in both categories. Mortality among admitted patients was 13%. Etiological diagnoses did not correspond to the guidelines of the Spanish Society of Pneumology and Chest Surgery (SEPAR), with microbial identification achieved in 5%. Empirical treatment followed SEPAR guidelines in 45% of the cases. The Mensa guidelines were followed in 23% and the Sanford guidelines in 20%.

Conclusions

The incidence of community-acquired pneumonia in this population is 3.2 cases per 1,000 inhabitants/year. The population is mainly elderly and comorbidity is common, although mortality is low. We believe common criteria should be adopted for managing community-acquired pneumonia and that empirical treatment should be directed toward germs identified in each setting, based on appropriate etiological investigation.

Key words:
Community-aequired pneumonia
Full text is only aviable in PDF
Bibliografía
[1.]
A. Telenti.
Estudio epidemiológico multicéntrico sobre neumonías en España.
Med Clin (Barc), 80 (1983), pp. 11-26
[2.]
M.A. Woodhead, J.T. MacFarlane, J.S. McCracken, D.H. Rose, R.G. Finch.
Prospective study of the aetiology and outcome of pneumonia in the community.
Lancet, 21 (1987), pp. 671-674
[3.]
T.J. Marrie.
Community-acquired pneumonia.
Clin Infect Dis, 18 (1994), pp. 501-515
[4.]
C. Jokinen, L. Heiskanen, H. Juvonen, et al.
Incidence of community-acquired pneumonia in the population of four municipalities in eastern Finland.
Am J Epidemiol, 137 (1993), pp. 977-988
[5.]
British Thoracic Society Research Committee, The Public Health Laboratory Service.
The aetiology, management and outcome of severe community-acquired pneumonia on the intensive care unit.
Respir Med, 86 (1992), pp. 7-13
[6.]
J. Dorca, S. Bello, J. Blanquer, et al.
Diagnóstico y tratamiento de la neumonía adquirida en la comunidad.
Arch Bronconeumol, 33 (1997), pp. 240-246
[7.]
J. Dorca, F. Manresa.
Community-acquired pneumonia: initial management and empirical treatment.
Eur Respir Mon, 2 (1997), pp. 36-55
[8.]
M.S. Niederman, J.B. Bass, G.D. Campbell, et al.
Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy.
Am Rev Respir Dis, 148 (1993), pp. 1.418-1.426
[9.]
G.D. Fang, M. Fine, J. Orloff, et al.
New and emerging etiologies for community-acquired pneumonia with implications for therapy: a prospective multicentre study of 359 cases.
Medicine (Baltimore), 69 (1990), pp. 307-316
[10.]
National Committee for Clinical Laboratory Standards.
Development of in vitro susceptibility testing criteria and quality control parameters.
NCCLS document M23-A., National Committee for Clinical Laboratory Standards, (1994),
[11.]
J.P. Sandford, D.N. Gilbert, M.A. Sande.
Guía de terapéutica antimicrobiana.
Ed. Díaz de Santos, S.A, (1996),
[12.]
J. Mensa, J.M. Gatell, M.T. Jiménez de Anta, G. Prats.
Guía de terapéutica antimicrobiana, 7.ª, Ed. Masson, (1997),
[13.]
Boletín Epidemiológico de Castilla y León. Ed. Consejería de Sanidad y Bienestar Social 1995; 11: 13-52.
[14.]
Boletín Epidemiológico de Castilla y León. Ed. Consejería de Sanidad y Bienestar Social 1996; 12: 1-12.
[15.]
M.J. Fine, M.A. Smith, C.A. Carson, et al.
Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis.
JAMA, 275 (1996), pp. 134-141
[16.]
R. Riquelme, A. Torres, M. El-Ebiary, et al.
Community acquired pneumonia in the elderly. A multivariate analysis of risk and prognostic factors.
Am J Respir Crit Care Med, 154 (1996), pp. 1.450-1.455
[17.]
P. Venkatesan, J. Gladman, J.T. MacFarlane, et al.
A hospital study of community-acquired pneumonia in the elderly.
Thorax, 45 (1990), pp. 254-258
[18.]
T.J. Marrie.
Epidemiology of community-acquired pneumonia in the elderly.
Semin Respir Infect, 5 (1990), pp. 260-268
[19.]
J. Hedlung, M. Kalin, A. Ortqvist.
Recurrence of pneumonia in middle-aged and elderly adults after hospital-treated pneumonia: aetiology and predisposing conditions.
Scand J Infect Dis, 29 (1997), pp. 387-392
[20.]
J.T. Macfarlane, R.G. Finch, M.J. Ward, A.D. Macrae.
Hospital study of adult community-acquired pneumonia.
Lancet, 2 (1982), pp. 255-258
[21.]
S. Limthongkul, P. Charoenlap, S. Wongthim, V. Udompanich, C. Nuchprayoon.
Bacterial pneumonia in the elderly.
J Med Assoc Thai, 77 (1994), pp. 169-175
[22.]
J.R. Ebright, M.W. Rytel.
Bacterial pneumonia in the elderly.
J Am Geriatr Soc, 28 (1980), pp. 220-223
[23.]
F.L. Brancati, J.W. Chow, N.M. Wagener, S.Y. Vacarello, V.L. Yu.
Is pneumonia really the old man's friend?.
Two year prognosis after community-acquired pneumonia. Lancet, 342 (1993), pp. 30-33
[24.]
A.L. Esposito, pneumonía. Community-acquired bacteremic pneumococcal.
Effect of age on manifestations and outcome.
Arch Inter Med, 144 (1984), pp. 945-948
[25.]
T.J. Marrie, E.V. Haldane, R.S. Faulkner, H. Durant, C. Kwan.
Community-acquired pneumonia requiring hospitalization: is it different in the elderly?.
J Am Geriatr Soc, 33 (1985), pp. 671-680
[26.]
G.M. Jong, T.R. Hsiue, C.R. Chen, H.Y. Chang, C.W. Chen.
Rapidly fatal outcome of bacteriemic Klebsiella pneumoniae pneumonia in alcoholics.
Chest, 107 (1995), pp. 214-217
[27.]
A. Torres, J. Serra-Batlles, A. Ferrer, et al.
Severe community-acquired pneumonia. Epidemiology and prognostic factors.
Am Rev Respir Dis, 114 (1991), pp. 312-318
[28.]
R. Kikuchi, N. Watabe, T. Konno, N. Mishima, K. Sekizawa, H. Sasaki.
High incidence of silent aspiration in elderly patients with community-acquired pneumonia.
Am J Respir Crit Care Med, 150 (1994), pp. 251-253
[29.]
A. Torres, J. Dorca, R. Zalacaín, et al.
Community-acquired pneumonia in chronic obstructive pulmonary disease. A Spanish Multicenter Study.
Am J Respir Crit Care Med, 154 (1996), pp. 1.456-1.461
[30.]
G.r. Donowitz, G.L. Mandell.
Neumonía aguda.
Enfermedades infecciosas. Principios y práctica,
[31.]
R. Zalacaín, N. Talayero, V. Achótegui, J. Corral, I. Barreña, V. Sobradillo.
Neumonía adquirida en la comunidad.
Fiabilidad de los criterios para decidir tratamiento ambulatorio. Arch Bronconeumol, 33 (1997), pp. 74-79
[32.]
J.I. Alós, M. Carnicero.
Consumo de antibióticos y resistencia bacteriana a los antibióticos: “algo que te concierne”.
Med Clin (Barc), 109 (1997), pp. 264-270
[33.]
T. Nebreda, F.J. Merino, A. Campos.
Epidemiología infecciosa en la provincia de Soria 1995..
Ed. INSALUD, (1996),
[34.]
M.A. Woodhead, J. Arrowsmith, R. Chamberlain-Weber, S. Wooding, I. Williams.
The value of routine microbial investigation in community-acquired pneumonia.
Respir Med, 85 (1991), pp. 313-317
[35.]
M.J. Fine, D.E. Singer, B.H. Hanusa, J.R. Lave, W.N. Kapoor.
Validation of a pneumonia prognostic index using the MedisGroups Comparative Hospital Database.
Am J Med, 94 (1993), pp. 153-159
[36.]
J. Pachon, M.D. Prados, F. Capote, J.A. Cuello, J. Garnacho, A. Verano.
Severe community-acquired pneumonia Etiology, prognosis, and treatment.
Am Rev Respir Dis, 142 (1990), pp. 369-373
[37.]
J. Relio, R. Rodríguez, P. Jubert, B. Álvarez.
Severe community-acquired pneumonia in the elderly: epidemiology and prognosis. Study Group for Severe Community-Acquired Pneumonia.
Clin Infect Dis, 23 (1996), pp. 723-728
[38.]
W.R. McNabb, D.C. Shanson, T.D. Williams, A.F. Lant.
Adult community-acquired pneumonia in central London.
J R Soc Med, 77 (1984), pp. 550-555
[39.]
J.P. Janssens, L. Gauthey, F. Herrmann, L. Tkatch, J.P. Michel.
Community-acquired pneumonia in older patients.
J Am Geriatr Soc, 44 (1996), pp. 539-544
Copyright © 1999. Sociedad Española de Neumología y Cirugía Torácica
Archivos de Bronconeumología
Article options
Tools

Are you a health professional able to prescribe or dispense drugs?